Among the most popular portfolio startups of the fund, we may highlight Kezar Life Sciences. We can highlight the next thriving fund investment areas, such as Life Science, Therapeutics.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Morningside Group, EcoR1 Capital. In the next rounds fund is usually obtained by Qiming Venture Partners, Pappas Ventures, Omega Funds.
The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| AFTERSHARE.TV | - |
| Brandenburg Kapital | Brandenburg, Germany, Potsdam |
| Brookside Equity Partners | Connecticut, Stamford, United States |
| Comercia Global Payments | Barcelona, Catalonia, Spain |
| CORFO | Chile, Region Metropolitana, Santiago |
| Direct Selling Capital | Dallas, Texas, United States |
| Egis | Auvergne-Rhône-Alpes, France, Saint-quentin |
| Fibonacci VC | China, Guangdong, Shenzhen |
| Great Noble International | - |
| iCloudUnion | Chengdu, China, Sichuan |
| Irwin Ventures | Columbus, Indiana, United States |
| Nima Capital | New York, New York, United States |
| NMT Capital | Massachusetts, Quincy, United States |
| Persistence Partners | California, Carpinteria, United States |
| Sajid Rahman | Indonesia, Jakarta, Jakarta Raya |
| Shanghai Qinghong Guyi Capital Management Center | - |
| Singapore EDB | Central, Central Region, Singapore |
| Weber Investissement | France, Ile-de-France, Paris |
| Zongshen Power | China, Chongqing, Chongqing Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kezar Life Sciences | $28M | 16 Jun 2015 | South San Francisco, California, United States | ||
Kezar Life Sciences | $23M | 05 Jun 2015 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kezar Life Sciences | $28M | 16 Jun 2015 | South San Francisco, California, United States | ||
Kezar Life Sciences | $23M | 05 Jun 2015 | South San Francisco, California, United States |
